Personalized cancer peptide vaccines are a form of cancer immunotherapy designed based on patient-specific mutation patterns (neoantigens). They activate the patient's own immune system to enable precise targeting and clearance of cancer cells.

Off-the-shelf cancer peptide vaccines are designed to target shared antigens of specific cancers, such as tumor-specific mutations or tumor-associated antigens, using peptides to elicit broad T-cell responses. These vaccines require no individualized design, making them suitable for large-scale recurrence prevention or combination with immunotherapy. By enhancing antigen presentation, activating CD8⁺ cytotoxic T cells, and modulating the tumor immune microenvironment, they provide broad and effective immune clearance across multiple tumor types.

AI-driven precision and comprehensive immune resolution integrates artificial intelligence, big data, immunology and clinical medicine to build state-of-the-art health management strategies. By analyzing personal immune status at multi-dimensional and multi-omic levels, the system can provide personalized immune interventions, disease prevention and treatment consultations.